These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15857187)

  • 1. Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer.
    Peters N; Domchek SM; Rose A; Polis R; Stopfer J; Armstrong K
    Genet Test; 2005; 9(1):48-53. PubMed ID: 15857187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interest in BRCA1/2 testing in a primary care population.
    Armstrong K; Weber B; Ubel PA; Guerra C; Schwartz JS
    Prev Med; 2002 Jun; 34(6):590-5. PubMed ID: 12052018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the knowledge and attitudes regarding genetic testing for breast cancer risk in our region of southeastern Georgia.
    MacNew HG; Rudolph R; Brower ST; Beck AN; Meister EA
    Breast J; 2010; 16(2):189-92. PubMed ID: 20030654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Referral and experience with genetic testing among women with early onset breast cancer.
    Brown KL; Hutchison R; Zinberg RE; McGovern MM
    Genet Test; 2005; 9(4):301-5. PubMed ID: 16379543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
    Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
    Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients.
    Ngoi N; Lee SC; Hartman M; Khin LW; Wong A
    Breast; 2013 Feb; 22(1):47-52. PubMed ID: 22560561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines.
    Hall J; Gray S; A'Hern R; Shanley S; Watson M; Kash K; Croyle R; Eeles R
    Fam Cancer; 2009; 8(1):5-13. PubMed ID: 18679829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching.
    Hallowell N; Foster C; Ardern-Jones A; Eeles R; Murday V; Watson M
    Genet Test; 2002; 6(2):79-87. PubMed ID: 12215246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing?
    Doksum T; Bernhardt BA; Holtzman NA
    Genet Med; 2003; 5(2):99-105. PubMed ID: 12644779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-counseling education materials for BRCA testing: does tailoring make a difference?
    Skinner CS; Schildkraut JM; Berry D; Calingaert B; Marcom PK; Sugarman J; Winer EP; Iglehart JD; Futreal PA; Rimer BK
    Genet Test; 2002; 6(2):93-105. PubMed ID: 12215248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.
    Peshkin BN; Isaacs C; Finch C; Kent S; Schwartz MD
    J Clin Oncol; 2003 Dec; 21(23):4322-8. PubMed ID: 14645421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
    Bellcross CA; Kolor K; Goddard KA; Coates RJ; Reyes M; Khoury MJ
    Am J Prev Med; 2011 Jan; 40(1):61-6. PubMed ID: 21146769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.